About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 624815, 12 pages
http://dx.doi.org/10.1155/2013/624815
Research Article

The Ehrlich Tumor Induces Pain-Like Behavior in Mice: A Novel Model of Cancer Pain for Pathophysiological Studies and Pharmacological Screening

1Departamento de Ciências Patológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Rod. Celso Garcia Cid KM480 PR445, 86051-990 Londrina, PR, Brazil
2Departamento de Ciências Fisiológicas, Centro de Ciências Biológicas, Universidade Estadual de Londrina, Rod. Celso Garcia Cid KM480 PR445, 86051-990 Londrina, PR, Brazil
3Departamento de Enfermagem, Centro de Ciências da Saúde, Universidade Estadual de Londrina, Avenida Robert Koch 60, 86038-350 Londrina, PR, Brazil
4Departamento Ciências Farmacêuticas, Centro de Ciências da Saúde, Universidade Estadual de Londrina, Avenida Robert Koch 60, 86038-350 Londrina, PR, Brazil

Received 29 April 2013; Accepted 10 July 2013

Academic Editor: Monica Fedele

Copyright © 2013 Cassia Calixto-Campos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. E. Greenberg, S. A. Leong, H. G. Birnbaum, and R. L. Robinson, “The economic burden of depression with painful symptoms,” Journal of Clinical Psychiatry, vol. 64, no. 7, pp. 17–23, 2003. View at Scopus
  2. C. R. Green, S. K. Ndao-Brumblay, and T. Hart-Johnson, “Sleep problems in a racially diverse chronic pain population,” Clinical Journal of Pain, vol. 25, no. 5, pp. 423–430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. W. F. Stewart, J. A. Ricci, E. Chee, D. Morganstein, and R. Lipton, “Lost productive time and cost due to common pain conditions in the US workforce,” Journal of the American Medical Association, vol. 290, no. 18, pp. 2443–2454, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. D. C. Turk, “Clinical effectiveness and cost-effectiveness of treatments for patients with chronic pain,” Clinical Journal of Pain, vol. 18, no. 6, pp. 355–365, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. K. O. Anderson, T. R. Mendoza, V. Valero et al., “Minority cancer patients and their providers: pain management attitudes and practice,” Cancer, vol. 88, no. 8, pp. 1929–1938, 2000.
  6. J. E. Nelson, D. E. Meier, E. J. Oei et al., “Self-reported symptom experience of critically ill cancer patients receiving intensive care,” Critical Care Medicine, vol. 29, no. 2, pp. 277–282, 2001. View at Scopus
  7. A. Caraceni, “Evaluation and assessment of cancer pain and cancer pain treatment,” Acta Anaesthesiologica Scandinavica, vol. 45, no. 9, pp. 1067–1075, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. C. R. Green, T. Hart-Johnson, and D. R. Loeffler, “Cancer-related chronic pain,” Cancer, vol. 117, no. 9, pp. 1994–2003, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. M. H. J. van den Beuken-van Everdingen, J. M. de Rijke, A. G. Kessels, H. C. Schouten, M. van Kleef, and J. Patijn, “Prevalence of pain in patients with cancer: a systematic review of the past 40 years,” Annals of Oncology, vol. 18, no. 9, pp. 1437–1449, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Sasamura, S. Nakamura, Y. Iida et al., “Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation,” European Journal of Pharmacology, vol. 441, no. 3, pp. 185–191, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Shimoyama, K. Tanaka, F. Hasue, and N. Shimoyama, “A mouse model of neuropathic cancer pain,” Pain, vol. 99, no. 1-2, pp. 167–174, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. M. J. Schwei, P. Honore, S. D. Rogers et al., “Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain,” Journal of Neuroscience, vol. 19, no. 24, pp. 10886–10897, 1999. View at Scopus
  13. P. W. Wacnik, L. J. Eikmeier, T. R. Ruggles et al., “Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain,” Journal of Neuroscience, vol. 21, no. 23, pp. 9355–9366, 2001. View at Scopus
  14. P. W. Mantyh, “Mechanisms of malignant bone pain,” in Cancer Pain: From Molecules to Suffering, A. J. Paice, R. F. Bell, E. A. Kalso, and O. A. Soyannwo, Eds., chapter 3, pp. 45–62, IASP Press, Washington, DC, USA, 1st edition, 2010.
  15. M. Kress, “Cytokines and cancer pain,” in Cancer Pain: From Molecules to Suffering, A. J. Paice, R. F. Bell, E. A. Kalso, and O. A. Soyannwo, Eds., chapter 4, pp. 63–84, IASP Press, Washington, DC, USA, 1st edition, 2010.
  16. P. Ehrlich and H. Apolant, “Beobachtungen uber maligne mausetumoren,” Berliner Klinische Wochenschrift, vol. 42, pp. 871–874, 1905.
  17. H. Loewenthal and G. Jahn, “Übertragunsversuche mit carcinomatöser Mäuse-Ascitesflüssigkeit und ihr Verhalten gegen physikalische und chemische Einwirkungen,” Zeitschrift für Krebsforschung, vol. 37, no. 1, pp. 439–447, 1932. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Ahmed, B. P. Chatterjee, and A. K. Debnath, “Interaction and in vivo growth inhibition of Ehrlich ascites tumor cells by jacalin,” Journal of Biosciences, vol. 13, no. 4, pp. 419–424, 1988. View at Scopus
  19. S. Kametani, T. Oikawa, A. Kojima-Yuasa et al., “Mechanism of growth inhibitory effect of cape aloe extract in Ehrlich ascites tumor cells,” Journal of Nutritional Science and Vitaminology, vol. 53, no. 6, pp. 540–546, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Balamurugan, B. V. Reddy, and V. P. Menon, “Antitumor and antioxidant role of Chrysaora quinquecirrha (sea nettle) nematocyst venom peptide against ehrlich ascites carcinoma in Swiss Albino mice,” Molecular and Cellular Biochemistry, vol. 338, no. 1-2, pp. 69–76, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Kumar, S. S. D'Souza, S. R. Mysore Nagaraj, S. L. Gaonkar, B. P. Salimath, and K. M. L. Rai, “Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1α in Ehrlich ascites tumor cells,” Cancer Chemotherapy and Pharmacology, vol. 64, no. 6, pp. 1221–1233, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Fastaia and A. E. Dumont, “Pathogenesis of ascites in mice with peritoneal carcinomatosis,” Journal of the National Cancer Institute, vol. 56, no. 3, pp. 547–550, 1976. View at Scopus
  23. F. Hartveit, “The immediate cause of death in mice with Ehrlich's ascites carcinoma,” Acta Pathologica et Microbiologica Scandinavica, vol. 65, no. 3, pp. 359–365, 1965. View at Scopus
  24. K. D. Mayer, “The pathogenicity of the Ehrlich ascites tumour,” British Journal of Experimental Pathology, vol. 47, no. 5, pp. 537–544, 1966. View at Scopus
  25. J. Vieira, P. Matsuzaki, M. K. Nagamine et al., “Inhibition of ascitic Ehrlich tumor cell growth by intraperitoneal injection of Pfaffia paniculata (Brazilian ginseng) butanolic residue,” Brazilian Archives of Biology and Technology, vol. 53, no. 3, pp. 609–613, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. X. Zhu, H. Wu, J. Xia, M. Zhao, and Z. Xianyu, “The relationship between T99mc-MIBI uptakes and tumor cell death/proliferation state under irradiation,” Cancer Letters, vol. 182, no. 2, pp. 217–222, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Brigatte, S. C. Sampaio, V. P. Gutierrez et al., “Walker 256 tumor-bearing rats as a model to study cancer pain,” Journal of Pain, vol. 8, no. 5, pp. 412–421, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. T. M. Cunha, W. A. Verri Jr., G. G. Vivancos et al., “An electronic pressure-meter nociception paw test for mice,” Brazilian Journal of Medical and Biological Research, vol. 37, no. 3, pp. 401–407, 2004. View at Scopus
  29. D. A. R. Valério, T. M. Cunha, N. S. Arakawa et al., “Anti-inflammatory and analgesic effects of the sesquiterpene lactone budlein A in mice: inhibition of cytokine production-dependent mechanism,” European Journal of Pharmacology, vol. 562, no. 1-2, pp. 155–163, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. S. J. Medhurst, K. Walker, M. Bowes et al., “A rat model of bone cancer pain,” Pain, vol. 96, no. 1-2, pp. 129–140, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. D. R. Clohisy, C. M. Ogilvie, and M. L. R. Ramnaraine, “Tumor osteolysis in osteopetrotic mice,” Journal of Orthopaedic Research, vol. 13, no. 6, pp. 892–897, 1995. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Menendéz, L. Juárez, V. García, A. Hidalgo, and A. Baamond, “Involvement of nitric oxide in the inhibition of bone cancer-induced hyperalgesia thought the activation of peripheral opioid receptors in mice,” Neuropharmacology, vol. 53, no. 1, pp. 71–80, 2007.
  33. Y. Kuraishi, Y. Iida, H. Zhang et al., “Suppression by gabapentin of pain-related mechano-responses in mice given orthotopic tumor inoculation,” Biological and Pharmaceutical Bulletin, vol. 26, no. 4, pp. 550–552, 2003. View at Scopus
  34. N. M. Luger, P. Honore, M. A. C. Sabino et al., “Osteoprotegerin diminishes advanced bone cancer pain,” Cancer Research, vol. 61, no. 10, pp. 4038–4047, 2001. View at Scopus
  35. R. K. Portenoy and G. Frager, “Pain management: pharmacological approaches,” Cancer Treatment and Research, vol. 100, pp. 1–29, 1999. View at Scopus
  36. M. Shimoyama, H. Tatsuoka, S. Ohtori, K. Tanaka, and N. Shimoyama, “Change of dorsal horn neurochemistry in a mouse model of neuropathic cancer pain,” Pain, vol. 114, no. 1-2, pp. 221–230, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. M. E. Mouedden and T. F. Meert, “Pharmacological evaluation of opioid and non-opioid analgesics in a murine bone cancer model of pain,” Pharmacology Biochemistry and Behavior, vol. 86, no. 3, pp. 458–467, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. O. Saito, T. Aoe, and T. Yamamoto, “Analgesic effects of nonsteroidal antiinflammatory drugs, acetaminophen, and morphine in a mouse model of bone cancer pain,” Journal of Anesthesia, vol. 19, no. 3, pp. 218–224, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Vissers, V. Hoffmann, F. Geenen, R. Biermans, and T. Meert, “Is the second phase of the formalin test useful to predict activity in chronic constriction injury models? A pharmacological comparison in different species,” Journal of World Institute of Pain, vol. 3, no. 4, pp. 298–309, 2003.
  40. W. G. Harris, E. A. Benson, D. Cartwright et al., “Symptoms and signs of operable breast cancer,” The Journal of the Royal College of General Practitioners, vol. 33, pp. 473–476, 1983.
  41. K. Kroner, B. Krebs, J. Skov, and H. S. Jorgensen, “Immediate and long-term phantom breast syndrome after mastectomy: incidence, clinical characteristics and relationship to pre-mastectomy breast pain,” Pain, vol. 36, no. 3, pp. 327–334, 1989. View at Scopus